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Abstract: Genome-wide associa-
tion study (GWAS) aims to discover
genetic factors underlying pheno-
typic traits. The large number of
genetic factors poses both compu-
tational and statistical challenges.
Various computational approaches
have been developed for large
scale GWAS. In this chapter, we will
discuss several widely used com-
putational approaches in GWAS.
The following topics will be cov-
ered: (1) An introduction to the
background of GWAS. (2) The
existing computational approaches
that are widely used in GWAS. This
will cover single-locus, epistasis
detection, and machine learning
methods that have been recently
developed in biology, statistic, and
computer science communities.
This part will be the main focus of
this chapter. (3) The limitations of
current approaches and future di-
rections.
This article is part of the ‘‘Transla-
tional Bioinformatics’’ collection for
PLOS Computational Biology.
1. Introduction
With the advancement of genotyping
technology, genome-wide high-density sin-
gle nucleotide polymorphisms (SNPs) of
human and other organisms are now
available [1,2]. The goal of genome-wide
association studies (GWAS) is to seek
strong associations between phenotype
and genetic variations in a population that
represent (genomically proximal) causal
genetic effects. As the most abundant
source of genetic variation, millions of
SNPs have been genotyped across the
entire genome. Analyzing such large
amount of markers poses great challenges
to traditional computational and statistical
methods. In this chapter, we introduce the
basic concept of genome-wide association
study, and discuss recently developed
methods for GWAS.
Genome-wide association study is an
inter-discipline problem of biology, statis-
tics and computer science [3,4,5,6]. In this
section, we will first provide a brief
introduction to the necessary biological
background. We will then formalize the
problem and discuss both traditional and
recently developed methods for genome-
wide analysis of associations.
A human genome contains over 3 billion
DNA base pairs. There are four possible
nucleotides at each base in the DNA:
adenine (A), guanine (G), thymine (T),
and cytosine (C). In some locations in the
genome, a genetic variation may be found
which involves two or more nucleotides
across different individuals. These genetic
variations are known as single-nucleotide
polymorphism (SNPs), i.e., a variation of a
single nucleotide in the DNA sequence. In
most cases, there are two possible nucleo-
tides for a variant. We denote the more
frequent one as ‘‘0’’, and the less frequent
one as ‘‘1’’. For bases on autosomal
chromosomes, there are two parallel nucle-
otides, which leads to three possible
combinations, ‘‘00’’, ‘‘01’’ and ‘‘11’’. These
genotype combinations are known as
‘‘major homozygous site’’, ‘‘heterozygous
site’’ and ‘‘minor heterozygous site’’ re-
spectively. These genetic variations con-
tribute to the phenotypic differences among
the individuals. (A phenotype is the com-
posite of an organism’s observable charac-
teristics or traits.) Genome-wide association
study (GWAS) aims to find strong associa-
tions between SNPs and phenotypes across
a set of individuals.
More formally, let X~fX1,X2,    ,
XNg be the set of N SNPs for M
individuals in the study, and Y be the
phenotype of interest. The goal of GWAS
is to find SNPs (markers) in X , that are
highly associated with Y . There are
several challenging issues that need to be
addressed when developing an analytic
method for GWAS [7,8].
Scalability Most GWAS datasets consist
of a large number of SNPs. Therefore the
algorithms for GWAS need to be highly
scalable. For example, for a typical human
GWAS, the dataset may contain up to
millions SNPs and involve thousands of
individuals. Inefficient methods may con-
sume a large amount of computational
resources and time to find highly associated
SNPs.
Missing markers Even with the
current dense genotyping technique, many
genetic variants are still not genotyped.
Current methods usually assume genetic
linkage to enhance the power. Imputation,
which tries to impute the unknown
markers by using existing SNPs databases,
is another popular approach to handle
missing markers. The well known related
projects include the International Hap-
Map project [9] and the 1000 Genomes
Project [10].
Complex traits One approach in
GWAS is to test the association between
the trait and each marker in a genome,
which is successful in detecting a single
gene related disease. However, this ap-
proach may have problems in finding
markers associated with complex traits.
This is because that complex traits are
affected by multiple genes, and each gene
may only have a weak association with the
phenotype. Such markers with low mar-
ginal effects are hard to detect by the
single-locus methods.
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In the remainder of the chapter, we will
first discuss the single-locus methods. We
will then study epistasis detection (multi-
locus) approaches which are designed for
association studies of complex traits. For
epistasis detection, we will mainly focus on




As the rapid development of high-
throughput genotyping technology, mil-
lions of SNPs are now available for
genome-wide association studies. Single-
locus association test is a traditional way
for association studies. Specifically, for
each SNP, a statistical test is performed
to evaluate the association between the
SNP and the phenotype. A variety of tests
can be applied depending on the data
types. The phenotype involved in a study
can be case-control (binary), quantitative
(continuous), or categorical. We categorize
the statistical tests based on what kind of
phenotypes they can be applied on.
2.1 Problem Formalization
Let fX1,    ,XNg be a set of N SNPs
for M individuals and Xn~fXn1,
   ,XnMg (1ƒnƒN). We use 0, 1, 2 to
represent the homozygous major allele,
heterozygous allele, and homozygous mi-
nor allele respectively. Thus we have that
Xnm[f0,1,2g (1ƒnƒN,1ƒmƒM ). Let
Y~fy1,    ,yMg be the phenotype. Note
that the values that Y can take depend on
its type.
2.2 Case-Control Phenotype
In a case-control study, the phenotype
can be represented as a binary variable
with 0 representing controls and 1 repre-
senting cases.
A contingency table records the
frequencies of different events. Table 1
is an example contingency table. For a
SNP Xn and a phenotype Y , and we use
Oij to denote the number of individuals













Many tests can be used to assess the
significance of the association between a
single SNP and a binary phenotype. The test
statistics are usually based on the contingency
table. The null hypothesis is that there is no
association between the rows and columns of
the contingency table.
2.2.1 Pearson’s x2 test. Pearson’s x2
test can be used to test a null hypothesis
stating that the frequency distribution of
certain events observed in a sample is
consistent with a particular theoretical
distribution [11].













. The degree of freedom
is 2.
2.2.2 G-test. G-test is an
approximation of the log-likelihood ratio.














The null hypothesis is that the observed
frequencies result from random sampling
from a distribution with the given expect-
ed frequencies. The distribution of G is
approximately that of x2, with the same
degree of freedom as in the corresponding
x2 test. When applied to a reasonable size
of samples, the G-test and the x2 test will
lead to the same conclusions.
2.2.3 Fisher exact test. When the
sample size is small, the Fisher exact test is
useful to determine the significance of the
association. The p-value of the test is the
probability of the contingency table given the
fixed margins. The probability of obtaining

















Most modern statistical packages can
calculate the significance of Fisher tests. The
actual computation performed by the existing
software packages may be different from the
exact formulation given above because of the
numerical difficulties. A simple, somewhat
better computational approach relies on a
gamma function or log-gamma function.
How to accurately compute hypergeometric
and binomial probabilities remains an active
research area.
2.2.4 Cochran-Armitage test. For
complex traits, contributions to disease
risk from SNPs are widely considered to be
roughly additive. In other words, the
heterozygous alleles will have an inter-
mediate risk between two homozygous
alleles. Cochran-Armitage test can be used












After substitution, we get
U~S:(O11z2O12{O1::(O:1z2O:2)
The variance of U under the null





Notice that for a large sample size S, we
have Uffiffiffiffiffiffiffiffiffiffiffi
Var(U)
p *N(0,1), hence U2
Var(U)
*x21.
2.2.5 Summary. There is no overall
winner of the introduced tests. Cochran-
Armitage test may not be the best if the risks
are deviated from the additive model.
Meanwhile, x2 test, G-test, and Fisher exact
test can handle the full range of risks, but they
will unavoidably lose some power in the
detection of additive ones. Different tests may
be applied on the same data to detect
different effects.
What to Learn in This Chapter
N The background of Genome-wide association study (GWAS).
N The existing computational approaches that are widely used in GWAS. This will
cover single-locus, epistasis detection, and machine learning methods.
N The limitations of current approaches and future directions.
Table 1. Contingency table for a single
SNP Xn and a phenotype Y .
Xn~0 Xn~1 Xn~2 Totals
Y~0 O00 O01 O02 O0:
Y~1 O10 O11 O12 O1:
Totals O:0 O:1 O:2 S
doi:10.1371/journal.pcbi.1002828.t001
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2.3 Quantitative Phenotype
In addition to case-control phenotypes,
many complex traits are quantitative. This
type of study is also often referred to as the
quantitative trait locus (QTL) analysis.
The standard tools for testing the associ-
ation between a single marker and a
continuous outcome are analysis of vari-
ance (ANOVA) and linear regression.
2.3.1 One-way ANOVA. The F-test
in one-way analysis of variance is used to
assess whether the expected values of a
quantitative variable within several pre-
defined groups differ from each other.
For each SNP Xn, we can divide all the
individuals into three groups according to
their genotypes. Let Y ’i (i[f0,1,2g) be a
subset of phenotypes of which the individ-
uals have the genotypes equal to i. We
represent the number of phenotypes in Y ’i








The total sum of squares (SST) can be
divided into two parts, the between-group
sum of squares (SSB) and the within-group








































The formula of F-test statistic is F~ SSB
SSW
,
and F follows the F-distribution with 2 and
S-3 degrees of freedom under the null
hypothesis, i.e., F*F(2,S{3).
2.3.2 Linear regression. In the
linear regression model, a least-squares
regression line is fit between the phenotype
values and the genotype values [11]. For
simplicity, we denote the genotypes of a
single SNP to be x1,x2,    ,xM . Based on
the data (x1,y1),    ,(xM ,yM ), we need to
fit a line in the form of Y~azbx.




























. To evaluate the significance of
the obtained model, a hypothesis testing
for b~0 is then applied.
2.4 Multiple Testing Problem
In a typical GWAS, the test needs to be
performed many times. We should pay
attention to a statistical issue known as the
multiple testing problem. In the remainder
of this section, we will discuss the multiple
testing problem and how to effectively
control error rate in GWAS.
Type 1 error rate, is the possibility that a
null hypothesis is rejected when it is actually
true. In other words, it is the chance of
observing a positive (significant) result even if
it is not. If a test is performed multiple times,
the overall Type 1 Error rate will increase.
This is called the multiple testing problem.
Let a be the type 1 error rate for a statistical
test. If the test is performed n times, the
experimental-wise error rate a’ is given by
a’~1{(1{a)n:
For example, if a~0:05 and n~20, then
a’~1{(1{0:05)20~0:64. In this case, the
chance of getting at least one false positive is
64%.
Because of the multiple testing problem,
the test result may not be that significant
even if its p-value is less than a significant
level a. To solve this problem, the nominal
p-value need to be corrected/adjusted.
2.5 Family-Wise Error Rate Control
For the single-locus test, we denote the p-
value for a association test of a SNP Xi and a
phenotype Y to be p(Xi,Y ), and the
corrected p-value to be p’(Xi,Y ). Family-wise
error rate (FWER), or the experiment-wise
error rate, is the probability of at least one false
association. We use a’ to denote family-wise
error rate, and it is given by
a’~P(reject H0DH0)~P reject at leastð
one of Hi(1ƒiƒn)DH0Þ,
where n is the total number of tests and H0 is
the hypothesis that all the Hi(1ƒiƒn) are
true.
Many methods can be used to control
FWER. Bonferroni correction is a com-
monly used method, in which p-values
need to be enlarged to account for the
number of comparisons being performed.
Permutation test [13] is also widely used to
correct for multiple testing in GWAS.
2.5.1 Bonferroni correction. In
Bonferroni correction, the p-value of a
test is multiplied by the number of tests in
the multiple comparison.
p’(Xi,Y )~p(Xi,Y ) N
Here the number of tests is the number of
SNPs N in a study. Bonferroni correction
is a single-step procedure, in which each of
the p-values is independently corrected.
2.5.2 Permutation tests. In the
permutation test, data are reshuffled. For
each permutation, p-values for all the tests are
re-calculated, and the minimal p-value is
retained. After K permutations, we get totally
K minimal p-values. The corrected p-value is
given by the proportion of minimal p-values
which is less than the original p-value.
Let fY1,    ,Ykg be the set of K
permutations. For each permutation
Yk(1ƒkƒK), the minimal p-value pYk
is given by
pYk~minfp(Xi,Yk)D1ƒiƒng:





The permutation method takes advantage of
the correlation structure between SNPs. It is
less stringent than Bonferroni correction.
2.6 False Discovery Rate Control
False discovery rate (FDR) controls the
expected proportion of type 1 error among all
significant hypotheses. It is less conservative
than the family-wise error rate. For example,
if 100 observed results are claimed to be
significant, and the FDR is 0.1, then 10 of
results are expected to be false discoveries.
One way to control the FDR is as
follows [14]. The p-values of SNPs and the
phenotype are ranked from smallest to
largest. We denote the ordered p-values to
be p1,    ,pN . Starting from the largest p-
value to the smallest, the original p-value is
multiplied by the total number of SNPs
and divided by its rank. For the ith p-value
pi, its corrected p-value p’i is given by
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In this section, we have discussed com-
monly used methods in single-locus study,
the multiple testing problem and how to
control error rate in GWAS. In the next
section, we will introduce methods used
for two-locus association studies. We will
focus on one class work that finds exact
solution when searching for SNP-SNP
interactions in GWAS.
3. Exact Methods for Two-Locus
Association Study
The vast number of SNPs has posed
great computational challenge to genome-
wide association study. In order to under-
stand the underlying biological mecha-
nisms of complex phenotype, one needs to
consider the joint effect of multiple SNPs
simultaneously. Although the idea of
studying the association between pheno-
type and multiple SNPs is straightforward,
the implementation is nontrivial. For a
study with total N SNPs, in order to find
the association between n SNPs and the






SNP combinations and evaluate their
associations with the phenotype. The
computational burden imposed by this
enormous search space often makes the
complete genome-wide association study
intractable. Moreover, although permuta-
tion test has been considered the gold
standard method for multiple testing
correction, it will dramatically increase
the computational burden because the
process needs to be performed for all
permuted data.
In this section, we will focus on the
recently developed exact method for two-
locus epistasis detection. Different from
the single-locus approach, the goal of two-
locus epistasis detection is to identify
interacting SNP-pairs that have strong
association with the phenotype. FastA-
NOVA [15] is an algorithm for two-locus
ANOVA (analysis of variance) test on
quantitative traits and FastChi [16] for
two-locus chi-square test on case-control
phenotypes. COE [17] is a general
method that can be applied in a wide
range of tests. TEAM [18] is designed for
studies involving a large number of
individuals such as human studies. In this
subsection, we will discuss these algo-
rithms, and their strengths and limita-
tions.
3.1 The FastANOVA Algorithm
FastANOVA utilizes an upper bound of
the two-locus ANOVA test to prune the
search space. The upper bound is ex-
pressed as the sum of two terms. The first
term is based on the single-SNP ANOVA
test. The second term is based on the
genotype of the SNP-pair and is indepen-
dent of permutations. This property allows
to index SNP-pairs in a 2D array based on
the genotype relationship between SNPs.
Since the number of entries in the 2D
array is bound by the number of individ-
uals in the study, many SNP-pairs share a
common entry. Moreover, it can be shown
that all SNP-pairs indexed by the same
entry have exactly the same upper bound.
Therefore, we can compute the upper
bound for a group of SNP-pairs together.
Another important property is that the
indexing structure only needs to be built
once and can be reused for all permutated
data. Utilizing the upper bound and the
indexing structure, FastANOVA only
needs to perform the ANOVA test on a
small number of candidate SNP-pairs
without the risk of missing any significant
pair. We discuss the algorithm in further
detail in the following.
Let fX1,X2,    ,XNg be the set of SNPs
of M individuals (Xi[f0,1g,1ƒiƒN) and
Y~fy1,y2,    ,yMg be the quantitative
phenotype of interest, where ym
(1ƒmƒM ) is the phenotype value of
individual m.
For any SNP Xi (1ƒiƒN ), we repre-
sent the F-statistic from the ANOVA test
of Xi and Y as F(Xi,Y ). For any SNP-
pair (XiXj), we represent the F-statistic
from the ANOVA test of (XiXj) and Y as
F (XiXj ,Y ).
The basic idea of ANOVA test is to
partition the total sum of squared devia-
tions SST into between-group sum of
squared deviations SSB and within-group
sum of squared deviations SSW :
SST~SSBzSSW :
In our application of the two-locus asso-
ciation study, Table 2 and Table 3 show
the possible groupings of phenotype values
by the genotypes of Xi and (XiXj)
respectively.
Let A, B, a1, a2, b1, b2 represent the
groups as indicated in Table 2 and
Table 3. We use SSB(Xi,Y ) and
SSB(XiXj ,Y ) to distinct the one locus
(i.e., single-SNP) and two locus (i.e., SNP-
pair) analyses. Specifically, we have
SST (Xi,Y )~SSB(Xi,Y )zSSW (Xi,Y ),
SST (XiXj ,Y )~SSB(XiXj ,Y )z
SSW (XiXj ,Y ):







SST (Xi,Y ){SSB(Xi,Y )
,
ð1:1Þ





SST (XiXj ,Y ){SSB(XiXj ,Y )
,
ð1:2Þ
where g in Equation (1.2) is the number of
groups that the genotype of (XiXj) parti-
tions the individuals into. Possible values
of g are 3 or 4, assuming all SNPs are
distinct: If none of groups A, B, a1, a2, b1,





ym be the sum of all
phenotype values. The total sum of
squared deviations does not depend on
the groupings of individuals:










ym be the sum of
phenotype values in a specific group, and
ngroup be the number of individuals in that
group. SSB(Xi,Y ) and SSB(XiXj ,Y ) can











Table 2. Grouping of Y by Xi .
Xi~1 Xi~0
group A group B
doi:10.1371/journal.pcbi.1002828.t002
Table 3. Grouping of Y by XiXj .
Xi~1 Xi~0
Xj~1 group a1 group b1
Xj~0 group a2 group b2
doi:10.1371/journal.pcbi.1002828.t003

















Note that for any group of A, B, a1, a2, b1,
b2, if ngroup~0, then
T2group
ngroup
is defined to be
0.
Let fymDym[Ag~fyA1 ,yA2 ,    ,yAnA g
be the phenotype values in group A.
Without loss of generality, assume that
these phenotype values are arranged in
ascending order, i.e.,
yA1ƒyA2ƒ   ƒyAnA :
Let fymDym[Bg~fyB1 ,yB2 ,    ,yBnB g be
the phenotype values in group B. Without
loss of generality, assume that these
phenotype values are arranged in ascend-
ing order, i.e.,
yB1ƒyB2ƒ   ƒyBnB :
We have the overall upper bound on
SSB(XiXj ,Y ):
Theorem 1 (Upper bound of SSB(Xi
Xj ,Y ))
SSB(XiXj ,Y )ƒSSB(Xi,Y )zR1(XiXjY )z
R2(XiXjY ):
The notations in the bound can be found
in Table 4. The upper bound in Theorem 1
is tight. The tightness of the bound is obvious
from the derivation of the upper bound, since
there exists some genotype of SNP-pair
(XiXj) that makes the equality hold.
We now discuss how to apply the upper
bound in Theorem 1 in detail. The set of
all SNP-pairs is partitioned into non-
overlapping groups such that the upper
bound can be readily applied to each
group. For every Xi (1ƒiƒN), let
AP(Xi) be the set of SNP-pairs
AP(Xi)~f(XiXj)Diz1ƒjƒNg:
For all SNP-pairs in AP(Xi), nA, TA, nB, TB
and SSB(Xi,Y ) are constants. Moreover,
la1 , ua1 are determined by na1 , and lb1 , ub1
are determined by nb1 . Therefore, in the
upper bound, na1 and nb1 are the only
variables that depend on Xj and may vary
for different SNP-pairs (XiXj) in AP(Xi).
Note that na1 is the number of 1’s in Xj
when Xi takes value 1, and nb1 is the number
of 1’s in Xj when Xi takes value 0. It is easy to
prove that switching na1 and na2 does not
change the F-statistic value and the correct-
ness of the upper bound. This is also true if
we switch nb1 and nb2 . Therefore, without
loss of generality, we can always assume that
na1 is the smaller one between the number of
1’s and number of 0’s in Xj when Xi takes
value 1, and nb1 is the smaller one between
the number of 1’s and number of 0’s in Xj
when Xi takes value 0.
If there are m 1’s and (M{m) 0’s in Xi,
then for any (XiXj)[AP(Xi), the possible
values that na1 can take are f0,1,2,    ,
tm=2sg. The possible values that nb1 can
take are f0,1,2,    ,t(M{m)=2sg.
To efficiently retrieve the candidates, the
SNP-pairs (XiXj) in AP(Xi) are grouped
by their (na1 ,nb1 ) values and indexed in a
2D array, referred to as Array(Xi).
Suppose that there are 32 individuals, and
the genotype of Xi consists of half 0’s and half
1’s. Thus for the SNP-pairs in AP(Xi), the
possible values of na1 and nb1 are
f0,1,2,    ,8g. Figure 1 shows the 9|9
array, Array(Xi), whose entries represent
the possible values of (na1 ,nb1 ) for the SNP-
pairs (XiXj)[AP(Xi). The entries in the same
column have the same na1 value. The entries
in the same row have the same nb1 value. The
na1 value of each column is noted beneath
each column. The nb1 value of each row is
noted left to each row. Each entry of the array
is a pointer to the SNP-pairs (XiXj)[AP(Xi)
having the corresponding (na1 ,nb1 ) values.
For any SNP Xi, the maximum number of
the entries in Array(Xi) is (qM4 rz1)
2. The
proof of this property is straightforward and
omitted here. In order to find candidate SNP-
pairs, we scan all entries in Array(Xi) to
calculate their upper bounds. Since the
SNP-pairs indexed by the same entry share
the same (na1 ,nb1 ) value, they have the same
upper bound. In this way, we can calculate
the upper bound for a group of SNP-pairs
together. Note that for typical genome-wide
association studies, the number of individuals
M is much smaller than the number of SNPs
N . Therefore, the additional cost for access-
ing Array(Xi) is minimal compared to
performing ANOVA tests for all pairs
(XiXj)[AP(Xi).
For multiple tests, permutation proce-
dure is often used in genetic analysis for
controlling family-wise error rate. For
genome-wide association study, permuta-
tion is less commonly used because it often
entails prohibitively long computation
times. Our FastANOVA algorithm makes
permutation procedure feasible in ge-
nome-wide association study.
Let Y ’~fY1,Y2,    ,YKg be the K
permutations of the phenotype Y . Following
the idea discussed above, the upper bound in
Theorem 1 can be easily incorporated in the
algorithm to handle the permutations. For
every SNP Xi, the indexing structure
Array(Xi) is independent of the permuted
phenotypes in Y ’. The correctness of this
property relies on the fact that, for any
(XiXj)[AP(Xi), na1 and nb1 only depend on
the genotype of the SNP-pair and thus
remain constant for different phenotype
permutations. Therefore, for each Xi, once
we build Array(Xi), it can be reused in all
permutations.
3.2 The FastChi Algorithm
As our initial attempt to develop scalable
algorithms for genome-wide association
study, FastANOVA is specifically designed
for the ANOVA test on quantitative pheno-
types. Another category of phenotypes is
generated in case-control study, where the
phenotypes are binary variables representing
disease/non-disease individuals. Chi-square
test is one of the most commonly used
statistics in binary phenotype association




















R2(XiXjY ) maxf(nBlb1 {nb1 TB)2,(nBub1 {nb1 TB)2g
nb1 (nB{nb1 )nB
doi:10.1371/journal.pcbi.1002828.t004
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study. We can extend the principles in
FastANOVA for efficient two-locus chi-
square test. The general idea of FastChi is
similar to that of FastANOVA, i.e., re-
formulating the chi-square test statistic to
establish an upper bound of two-locus chi-
square test, and indexing the SNP-pairs
according to their genotypes in order to
effectively prune the search space and reuse
redundant computations. Here we briefly
introduce the FastChi algorithm.
For SNP Xi, we represent the chi-square
test value of Xi and the binary phenotype Y as
x2(Xi,Y ). For any SNP-pair Xi and Xj , we
use x2(XiXj ,Y ) to represent the chi-square
test value for the combined effect of (XiXj)
with Y . Let A,B,C,D represent the following
events respectively: Y~0 ^ Xi~0; Y~0^
Xi~1; Y~1 ^ Xi~0; Y~1 ^ Xi~1. Let
Oevent denote the observed value of an event.
T1, T2, S1, S2, R1, and R2 represent the
formulas shown in Table 5. We have the
upper bound of x2(XiXj ,Y ) stated in
Theorem 2.





For given phenotype Y and SNPXi,
x2(Xi,Y ), T1, S1, T2, and S2 are constants.
R1 and R2 are the only variables that
depend on Xj and may vary for different
SNP-pairs (XiXj)[AP(Xi). (Recall that
AP(Xi)~f(XiXj)Diz1ƒjƒNg.) Thus for
a given Xi, we can treat equation
x2(Xi,Y )zT1S1R1zT2S2R2~h as a
straight line in the 2-D space of R1 and R2.
The ones whose (R1(XiXj),R2(XiXj)) val-
ues fall below the line can be pruned without
any further test.
Suppose that there are 32 individuals, Xi
contains half 0’s, and half 1’s. For the
SNP-pairs in AP(Xi), the possible values of



























g. Figure 2 shows the 2-D space
of R1 and R2. The blue stars represent the
values that (R1,R2) can take. The line
x2(Xi,Y )zT1S1R1zT2S2R2~h is plot-
ted in the figure. Only the SNP-pairs whose
(R1,R2) values are in the shaded region are
subject to two-locus Chi-square test.
Similar to FastANOVA, in FastChi, we
can index the SNP-pairs in AP(Xi) accord-
ing to their genotype relationships, i.e., by the
values of (R1,R2). Experimental results
demonstrate that FastChi is an order of
magnitude faster than the brute force
alternative.
3.3 The COE Algorithm
Both FastANOVA and FastChi rework the
formula of ANOVA test and Chi-square test
to estimate an upper bound of the test value
for SNP pairs. These upper bounds are used
to identify candidate SNP pairs that may have
strong epistatic effect. Repetitive computation
in a permutation test is also identified and
performed once those results are stored for use
by all permutations. These two strategies lead
to substantial speedup, especially for large
permutation test, without compromising the
accuracy of the test. These approaches
guarantee to find the optimal solutions.
However, a common drawback of these
methods is that they are designed for specific
tests, i.e., chi-square test and ANOVA test.
The upper bounds used in these methods do
not work for other statistical tests, which are
Figure 1. The index array Array(Xi) for efficient retrieval of the candidate SNP-pairs.
doi:10.1371/journal.pcbi.1002828.g001
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also routinely used by researchers. In addition,
new statistics for epistasis detection are
continually emerging in the literature. There-
fore, it is desirable to develop a general model
that supports a variety of statistical tests.
The COE algorithm takes the advantage
of convex optimization. It can be shown that
a wide range of statistical tests, such as
chi-square test, likelihood ratio test (also
known as G-test), and entropy-based tests
are all convex functions of observed frequen-
cies in contingency tables. Since the maxi-
mum value of a convex function is attained at
the vertices of its convex domain, by
constraining on the observed frequencies in
the contingency tables, we can determine the
domain of the convex function and get its
maximum value. This maximum value is
used as the upper bound on the test statistics
to filter out insignificant SNP-pairs. COE is
applicable to all tests that are convex.
3.4 The TEAM Algorithm
The methods we have discussed so far
provide promising alternatives for GWAS.
However, there are two major drawbacks that
limit their applicability. First, they are designed
for relatively small sample size and only
consider homozygous markers (i.e., each
SNP can be represented as a f0,1g binary
variable). In human study, the sample size is
usually large and most SNPs contain hetero-
zygous genotypes and are coded using
f0,1,2g. These make previous methods
intractable. Second, although the family-wise
error rate (FWER) and the false discovery rate
(FDR) are both widely used for error
controlling, previous methods are designed
only to control the FWER. From a compu-
tational point of view, the difference in the
FWER and the FDR controlling is that, to
estimate FWER, for each permutation, only
the maximum two-locus test value is needed.
To estimate the FDR, on the other hand, for
each permutation, all two-locus test values
must be computed.
To address these limitations, TEAM is
proposed for efficient epistasis detection in
human GWAS. TEAM has several advan-
tages over previous methods. It supports to
both homozygous and heterozygous data. By
exhaustively computing all two-locus test
values in permutation test, it enables both
FWER and FDR controlling. It is applicable
to all statistics based on the contingency table.
Previous methods are either designed for
specific tests or require the test statistics satisfy
certain property. Experimental results dem-
onstrate that TEAM is more efficient than
existing methods for large sample studies.
TEAM incorporates the permutation test
for proper error controlling. The key idea is
to incrementally update the contingency
tables of two-locus tests. We show that only
four of the eighteen observed frequencies in
the contingency table need to be updated to
compute the test value. In the algorithm, we
build a minimum spanning tree [19] on the
SNPs. The nodes of the tree are SNPs. Each
edge represents the genotype difference
between the two connected SNPs. This tree
structure can be utilized to speed up the
updating process for the contingency tables.
A majority of the individuals are pruned and
only a small portion are scanned to update
the contingency tables. This is advantageous
in human study, which usually involves
Figure 2. Pruning SNP-pairs in AP(Xi) using the upper bound.
doi:10.1371/journal.pcbi.1002828.g002
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thousands of individuals. Extensive experi-
mental results demonstrate the efficiency of
the TEAM algorithm.
As a summary of the exact two-locus
algorithms, FastANOVA and FastChi are
designed for specific tests and binary geno-
type data. The COE algorithm is a more
general method that can be applied to all
convex tests. The TEAM algorithm is more




(MDR) [20] is a data mining method to
identify interactions among discrete variables
for binary outcomes. It can be used to detect
high-order gene-gene and gene-environment
interactions in case-control studies. By pooling
multi-locus SNPs into two groups, one
classified as high-risk and the other classified
as low risk, MDR effectively reduces the
predictors from n dimensions to one dimen-
sion. Then, the one-dimensional variable is
evaluated through cross-validation. The steps
are repeated for all other n factor combina-
tions, and the factor model which has the
lowest prediction error is chosen as the ‘best’ n
factor model. Its detailed steps are as follows:
N Divide the set of factors into 10 equal
subsets.
N Select a set of n factors from the pool
of all factors in the training set
N Create a contingency table for these n
factors by counting the number of cases
and controls in each combination.
N Compute the case-control ratio in each
combination. Label them as ‘‘high-risk if
it is greater than a certain threshold, and
otherwise, it is marked as ‘‘low-risk’’.
N Use the labels to classify individuals.
Compute the misclassification rate.
N Repeat previous steps for all combina-
tions of n factors across 10 training and
testing subsets.
N Choose the model whose average
misclassification rate is minimized
and cross-validation consistency is
maximized as the ‘‘best’’ model.
MDR designs a constructive induction
method that combines two or more SNPs
before testing for association. The power of
the MDR approach is that it can be
combined with other methodologies includ-
ing the ones described in this chapter.
5. Logistic Regression
Logistic regression is a statistical method
for predicting binary and categorical out-
come. It is widely used in GWAS [21,22].
The basic idea is to use linear regression to
model the probability of the occurrence of a
specific outcome. Logistic regression is appli-
cable to both single-locus and multi-locus
association studies and can incorporate
covariates and other factors in the model.
Let Y[f0,1g be a binary variable
representing disease status (diseased verses
non diseased), and X[f0,1,2g be a SNP.
The conditional probability of having the
disease given a SNP is h(X )~P(Y~1DX ).
We define the logit function to convert the






The logit can be considered as a latent
continuous variable that will be fit to a
linear predictor function:
logit(X )*b0zb  X :
To cope with multiple SNP loci and
potential covariates, we can modify the
above model. For example, in the follow-
ing model the logit is fit with predictors of
SNPs (X1, X2) and covariates (Z1, Z2):
logit(X )*b0zb1  X1zb2  X2zb3
X1  X2zb4  Z1zb5  Z2:
Although logistic regression can handle
complicated models, it may be computa-
tionally demanding when the number of
predictors is large [23].
6. Summary
The potential of genome-wide association
study for the identification of genetic variants
that underlying phenotypic variations is well
recognized. The availability of large SNP data
generated by high-throughput genotyping
methods poses great computational and
statistical challenges. In this chapter, we have
discussed serval computational approaches to
detect associations between genetic markers
and the phenotypes. For further readings, the
readers are encouraged to refer to [11,7,24,25]
for discussions about current progress and
challenges in large-scale genetic association
studies.
7. Exercises
Question 1: The table below con-
tains binary genotype and case-control
phenotype data from ten individuals.
Give the contingency table and use x2

























Question 2: Assuming that we have
the following SNP and phenotype data, is
the SNP significantly associated with the
phenotype? Here, we represent each SNP
site as the number of minor alleles on that
locus, so 0 and 2 are for major and minor
homozygous sites, respectively, and 1 is for
the heterozygous sites. We also assume
that minor alleles contribute to the phe-
notype and the effect is additive. In other
words, the effect from a minor homozy-
gous site should be twice as large as that
from a heterozygous site. You may use any
test methods introduced in the chapter.
























Question 3: Categorize the following
methods in the table. The methods are x2
test, G-test, ANOVA, Student’s T-test,
Pearson’s correlation, linear regression,
logistic regression.
case control phenotype quantitative phenotype
Question 4: Why is it important to
study multiple-locus association? What are
the challenges?
Answers to the Exercises can be found
in Text S1.
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Supporting Information
Text S1 Answers to Exercises
(PDF)
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